Eli Lilly Stock’s impressive results have made her a sensation, while Obesity Drugs has delivered the goods.
Eli Lilly’s Mounjaro diabetes treatment sales in the second quarter were significantly higher than expected by Wall Street estimates, resulting in a significant increase in stock and increased investor interest.
The message is from To Message.
The concept of SEND is well-known.
Please try again later, this error has been corrected.